Emerging Therapeutic Agents and Nanotechnology-Driven Innovations in Psoriasis Management

Emerging Therapeutic Agents and Nanotechnology-Driven Innovations in Psoriasis Management

Blog Article

Psoriasis has been a rising concern for over a decade, imposing significant challenges HERBATINT 5M to individuals and society.Traditional topical therapy is non-targeted and acts systemically, with associated side effects.This increases the global burden both socially and economically.

This review covers the evolution of drug molecules and nanotechnology-based approaches for the topical treatment of psoriasis, a chronic inflammatory skin disorder with no known etiology.Nanotechnology-based approaches offer promising solutions by reducing side effects, providing targeted delivery, protecting Wind Chimes drug molecules from degradation, enhancing skin retention, and providing controlled release.Researchers have investigated the incorporation of various conventional and non-conventional therapeutic agents into nanocarriers for psoriasis treatment.

The current understanding of the disease and its treatment using various therapeutic agents combined with novel formulation strategies will reduce the duration of treatment and improve the quality of life in psoriatic disease conditions.